| Regulatory Story | ||||||||||||
| Go to market news section |
|
|||||||||||
|
||||||||||||
Dexion Absolute Limited: Transaction in own shares
Dexion Absolute Limited (the "Company") announces that on 15 March 2013 it purchased 125,000 of its GBP shares of no par value, at the following price per share:
|
Number of Shares |
Price (p) |
|
125,000 |
146.99p |
The GBP shares purchased will be held in Treasury. Following the above purchase, the Company holds 8,881,500 GBP shares, Nil EUR shares and Nil USD shares in Treasury. Following the above purchase, the total number of GBP shares in issue (excluding treasury shares) is 258,663,019 the total number of EUR shares in issue (excluding treasury shares) is 2,977,869 and the total number of USD shares in issue (excluding treasury shares) is 8,040,174.
Accordingly, the current issued share capital consists of 269,681,062 ordinary shares with voting rights. Shareholders may use this figure as the denominator for the calculations by which they determine whether they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules.
![]() |
![]() |
| London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply. |
| © London Stock Exchange plc. All rights reserved |